FMP

FMP

Enter

INBX - Inhibrx Bi...

photo-url-https://images.financialmodelingprep.com/symbol/INBX.png

Inhibrx Biosciences, Inc.

INBX

NASDAQ

Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates includes INBRX-109, a tetravalent therapeutic candidate targeting death-receptor 5 that is in phase 2 clinical trial for the treatment of unresectable or metastatic conventional chondrosarcoma; and INBRX-106, a hexavalent sdAb-based therapeutic candidate targeting OX4 that is in phase 2 clinical trial for the treatment of metastatic solid tumor, non-small cell lung cancer, melanoma, head and neck cancer, gastric (GIST) and gastroesophageal adenocarcinoma (GEA) cancer, renal cell carcinoma, and urothelial (transitional) cell carcinoma. The company was incorporated in 2024 and is based in La Jolla, California.

14.1 USD

-0.05 (-0.355%)

Build Up Free Cash Flow

Year

2018

2019

2020

2021

2022

2023

2024

2025

2026

2027

Revenue

3.22B

3.08B

3.34B

3.8B

4.13B

4.41B

4.7B

5.02B

5.35B

5.71B

Operating Cash Flow

212.7M

245M

369.7M

252.2M

256.3M

339.29M

361.95M

386.12M

411.91M

439.41M

Cap Ex

-167.6M

-104.5M

-94M

-150.3M

-184.9M

-174.99M

-186.68M

-199.14M

-212.44M

-226.63M

Free Cash Flow

45.1M

140.5M

275.7M

101.9M

71.4M

164.3M

175.27M

186.98M

199.46M

212.79M

Wacc

5.59

5.59

5.59

5.59

5.59

Pv Lfcf

155.6M

157.21M

158.83M

160.47M

162.12M

Sum Pv Lfcf

794.24M

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedin
2017-2024 © Financial Modeling Prep